• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚太地区儿童胃肠疾病益生菌治疗:建议草案。

Probiotics for gastrointestinal disorders: Proposed recommendations for children of the Asia-Pacific region.

机构信息

Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Melbourne 3052, Australia.

Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.

出版信息

World J Gastroenterol. 2017 Dec 7;23(45):7952-7964. doi: 10.3748/wjg.v23.i45.7952.

DOI:10.3748/wjg.v23.i45.7952
PMID:29259371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5725290/
Abstract

Recommendations for probiotics are available in several regions. This paper proposes recommendations for probiotics in pediatric gastrointestinal diseases in the Asia-Pacific region. Epidemiology and clinical patterns of intestinal diseases in Asia-Pacific countries were discussed. Evidence-based recommendations and randomized controlled trials in the region were revised. Cultural aspects, health management issues and economic factors were also considered. Final recommendations were approved by applying the Likert scale and rated using the GRADE system. (Sb) and () were strongly recommended as adjunct treatment to oral rehydration therapy for gastroenteritis. could also be considered. Probiotics may be considered for prevention of (with the indicated strains): antibiotic-associated diarrhea (LGG or Sb); -induced diarrhea (Sb); nosocomial diarrhea (LGG); infantile colic () and as adjunct treatment of (Sb and others). Specific probiotics with a history of safe use in preterm and term infants may be considered in infants for prevention of necrotizing enterocolitis. There is insufficient evidence for recommendations in other conditions. Despite a diversity of epidemiological, socioeconomical and health system conditions, similar recommendations apply well to Asia pacific countries. These need to be validated with local randomized-controlled trials.

摘要

在多个地区都有关于益生菌的推荐意见。本文提出了亚太地区儿科胃肠疾病的益生菌推荐意见。讨论了亚太国家肠道疾病的流行病学和临床模式。修订了该地区基于循证的推荐意见和随机对照试验。还考虑了文化方面、健康管理问题和经济因素。最终建议应用李克特量表进行批准,并使用 GRADE 系统进行评级。(Sb)和()强烈推荐作为胃肠炎口服补液治疗的辅助治疗。也可以考虑。益生菌可用于预防(用指示菌株):抗生素相关性腹泻(LGG 或 Sb);艰难梭菌相关性腹泻(Sb);医院获得性腹泻(LGG);婴儿绞痛()和辅助治疗(Sb 和其他)。对于预防坏死性小肠结肠炎,在早产儿和足月儿中具有安全使用史的特定益生菌可在婴儿中考虑。其他情况下的建议证据不足。尽管存在多种流行病学、社会经济和卫生系统状况,但类似的建议很好地适用于亚太国家。这些建议需要通过当地的随机对照试验进行验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2466/5725290/3e3c966d9184/WJG-23-7952-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2466/5725290/f751815391ba/WJG-23-7952-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2466/5725290/3e3c966d9184/WJG-23-7952-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2466/5725290/f751815391ba/WJG-23-7952-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2466/5725290/3e3c966d9184/WJG-23-7952-g002.jpg

相似文献

1
Probiotics for gastrointestinal disorders: Proposed recommendations for children of the Asia-Pacific region.亚太地区儿童胃肠疾病益生菌治疗:建议草案。
World J Gastroenterol. 2017 Dec 7;23(45):7952-7964. doi: 10.3748/wjg.v23.i45.7952.
2
Recommendations for the adjuvant use of the poly-antibiotic-resistant probiotic (O/C, SIN, N/R, T) in acute, chronic, and antibiotic-associated diarrhea in children: consensus from Asian experts.亚洲专家共识:多抗生素耐药益生菌(O/C、SIN、N/R、T)在儿童急性、慢性及抗生素相关性腹泻中的辅助应用建议
Trop Dis Travel Med Vaccines. 2020 Oct 23;6:21. doi: 10.1186/s40794-020-00120-4. eCollection 2020.
3
The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts.益生菌在儿科胃肠病学中的应用:文献综述及拉丁美洲专家的建议。
Paediatr Drugs. 2015 Jun;17(3):199-216. doi: 10.1007/s40272-015-0124-6.
4
Probiotics for Prevention and Treatment of Diarrhea.用于预防和治疗腹泻的益生菌
J Clin Gastroenterol. 2015 Nov-Dec;49 Suppl 1:S37-45. doi: 10.1097/MCG.0000000000000349.
5
The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia-Pacific region - background and recommendations of a regional consensus meeting.亚太地区成人胃肠道疾病中微生物组的作用和益生菌的应用——区域共识会议的背景和建议。
J Gastroenterol Hepatol. 2018 Jan;33(1):57-69. doi: 10.1111/jgh.13840.
6
Prophylactic use of probiotics for gastrointestinal disorders in children.益生菌预防儿童胃肠道疾病的应用。
Lancet Child Adolesc Health. 2019 Sep;3(9):655-662. doi: 10.1016/S2352-4642(19)30182-8. Epub 2019 Jul 3.
7
Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children.《细菌与肠道:益生菌在儿童胃肠道疾病中的实际应用》
Nutr Clin Pract. 2015 Dec;30(6):747-59. doi: 10.1177/0884533615610081.
8
Probiotics for prevention and treatment of diarrhea.益生菌预防和治疗腹泻。
J Clin Gastroenterol. 2011 Nov;45 Suppl:S149-53. doi: 10.1097/MCG.0b013e3182257e98.
9
Protection from gastrointestinal diseases with the use of probiotics.使用益生菌预防胃肠道疾病。
Am J Clin Nutr. 2001 Feb;73(2 Suppl):430S-436S. doi: 10.1093/ajcn/73.2.430s.
10
Health benefits of GG and subspecies BB-12 in children.GG 和亚种 BB-12 对儿童的健康益处。
Postgrad Med. 2020 Jun;132(5):441-451. doi: 10.1080/00325481.2020.1731214. Epub 2020 Feb 26.

引用本文的文献

1
Impact of Obesity on Immunity to the Influenza Virus: Gut Microbiota, Mechanisms, and Novel Therapeutic Strategies.肥胖对流感病毒免疫的影响:肠道微生物群、机制及新型治疗策略
Diseases. 2025 Aug 19;13(8):267. doi: 10.3390/diseases13080267.
2
Clostridioides difficile Infections: Prevention and Treatment Strategies.艰难梭菌感染:预防与治疗策略。
Adv Exp Med Biol. 2024;1449:175-186. doi: 10.1007/978-3-031-58572-2_11.
3
Unique Properties of Yeast Probiotic Saccharomyces boulardii CNCM I-745: A Narrative Review.酵母益生菌布拉酵母菌CNCM I-745的独特特性:一篇叙述性综述。

本文引用的文献

1
Long-term safety and efficacy of perinatal probiotic intervention: Evidence from a follow-up study of four randomized, double-blind, placebo-controlled trials.围产期益生菌干预的长期安全性和有效性:来自四项随机、双盲、安慰剂对照试验随访研究的证据。
Pediatr Allergy Immunol. 2017 Mar;28(2):170-175. doi: 10.1111/pai.12675. Epub 2016 Dec 23.
2
Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis.益生菌预防坏死性小肠结肠炎:一项系统评价与荟萃分析。
PeerJ. 2016 Oct 5;4:e2429. doi: 10.7717/peerj.2429. eCollection 2016.
3
Efficacy of Probiotic Supplementation Therapy for Helicobacter pylori Eradication: A Meta-Analysis of Randomized Controlled Trials.
Cureus. 2023 Oct 1;15(10):e46314. doi: 10.7759/cureus.46314. eCollection 2023 Oct.
4
Effects of Probiotics in Adults with Gastroenteritis: A Systematic Review and Meta-Analysis of Clinical Trials.益生菌对成人肠胃炎的影响:一项临床试验的系统评价和荟萃分析
Diseases. 2023 Oct 11;11(4):138. doi: 10.3390/diseases11040138.
5
Qualitative Analysis of the Efficacy of Probiotic Strains in the Prevention of Antibiotic-Associated Diarrhea.益生菌菌株预防抗生素相关性腹泻疗效的定性分析
Cureus. 2023 Jun 11;15(6):e40261. doi: 10.7759/cureus.40261. eCollection 2023 Jun.
6
Strain GG (LGG) Regulate Gut Microbial Metabolites, an In Vitro Study Using Three Mature Human Gut Microbial Cultures in a Simulator of Human Intestinal Microbial Ecosystem (SHIME).鼠李糖乳杆菌GG株(LGG)对肠道微生物代谢产物的调节作用:在人体肠道微生物生态系统模拟器(SHIME)中使用三种成熟的人体肠道微生物培养物进行的体外研究
Foods. 2023 May 24;12(11):2105. doi: 10.3390/foods12112105.
7
The pathogenesis of gut microbiota in hepatic encephalopathy by the gut-liver-brain axis.肝性脑病通过肠-肝-脑轴的肠道微生物组发病机制。
Biosci Rep. 2023 Jun 28;43(6). doi: 10.1042/BSR20222524.
8
A Real-World Perspective of Co-amoxiclav Prescription Pattern With Probiotics for Pediatric Patients With Respiratory Tract Infections: Results of Quantitative and Qualitative Approach in Indian Outpatient Settings.印度门诊环境中儿童呼吸道感染患者使用含益生菌的阿莫西林克拉维酸钾处方模式的真实世界视角:定量和定性方法的结果
Cureus. 2023 Mar 16;15(3):e36269. doi: 10.7759/cureus.36269. eCollection 2023 Mar.
9
Clostridioides difficile bile salt hydrolase activity has substrate specificity and affects biofilm formation.艰难梭菌胆汁盐水解酶活性具有底物特异性,并影响生物膜的形成。
NPJ Biofilms Microbiomes. 2022 Nov 30;8(1):94. doi: 10.1038/s41522-022-00358-0.
10
Persistence of the Probiotic Strain GG (LGG) in an In Vitro Model of the Gut Microbiome.益生菌菌株 GG(LGG)在肠道微生物组体外模型中的持久性。
Int J Mol Sci. 2022 Oct 26;23(21):12973. doi: 10.3390/ijms232112973.
补充益生菌治疗幽门螺杆菌根除的疗效:一项随机对照试验的荟萃分析。
PLoS One. 2016 Oct 10;11(10):e0163743. doi: 10.1371/journal.pone.0163743. eCollection 2016.
4
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 V/佛罗伦萨共识报告。
Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.
5
Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study.运用定量分子诊断方法确定儿童腹泻病因:全球儿童急性腹泻病监测研究病例对照研究的重新分析
Lancet. 2016 Sep 24;388(10051):1291-301. doi: 10.1016/S0140-6736(16)31529-X.
6
Randomised clinical trial: a Lactobacillus GG and micronutrient-containing mixture is effective in reducing nosocomial infections in children, vs. placebo.随机临床试验:与安慰剂相比,含鼠李糖乳杆菌GG和微量营养素的混合物可有效减少儿童医院感染。
Aliment Pharmacol Ther. 2016 Sep;44(6):568-75. doi: 10.1111/apt.13740. Epub 2016 Jul 28.
7
Hospital Based Prospective Observational Study to Audit the Prescription Practices and Outcomes of Paediatric Patients (6 months to 5 years age group) Presenting with Acute Diarrhea.一项基于医院的前瞻性观察性研究,旨在审核患有急性腹泻的儿科患者(6个月至5岁年龄组)的处方用药情况及治疗结果。
J Clin Diagn Res. 2016 May;10(5):SC01-5. doi: 10.7860/JCDR/2016/19924.7810. Epub 2016 May 1.
8
Indications and Recommendations by Societies and Institutions for the Use of Probiotics and Prebiotics in Paediatric Functional Intestinal Disorders.各学会和机构关于益生菌和益生元在儿童功能性肠道疾病中应用的适应症及建议
J Pediatr Gastroenterol Nutr. 2016 Jul;63 Suppl 1:S36-7. doi: 10.1097/MPG.0000000000001220.
9
Probiotics for Irritable Bowel Syndrome: Clinical Data in Children.用于治疗儿童肠易激综合征的益生菌:临床数据
J Pediatr Gastroenterol Nutr. 2016 Jul;63 Suppl 1:S25-6. doi: 10.1097/MPG.0000000000001220.
10
Probiotics for the Management of Infantile Colic.益生菌用于婴儿腹绞痛的管理
J Pediatr Gastroenterol Nutr. 2016 Jul;63 Suppl 1:S22-4. doi: 10.1097/MPG.0000000000001220.